Salvage Cryosurgery of the Prostate After Radiation Failure

Overview

Journal Rev Urol

Date 2006 Sep 21

PMID 16985867

Citations 4

Authors

John S Lam

Arie S Belldegrun

Affiliations

Soon will be listed here.

Abstract

Radiation therapy is one option for patients with localized prostate cancer. Despite advances in delivering radiation to the prostate gland with therapies such as brachytherapy and/or external beam radiation therapy, urologists will be faced with managing patients with rising prostate-specific antigen values and with positive biopsy results secondary to radiation-recurrent prostate cancer. If the cancer is detected early, salvage therapy can be initiated. Since salvage prostatectomy is associated with significant morbidity, patients are often left with the option of either watchful waiting or temporary palliation with hormone deprivation therapy, with its attendant toxicity. The introduction of third-generation cryotechnology using 17-gauge CryoNeedlestrade mark (Oncura, Inc., Plymouth Meeting, PA) and the recent modifications in the technique of salvage cryosurgery have enabled cryosurgeons to eradicate these tumors safely and with significantly decreased morbidity. Selection and management of patients, as well as the contemporary results of salvage cryosurgery, are discussed in this article.

Citing Articles

Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy.

Munoz O, Gomis Selles E, Delgado Leon B, Mateos Perez J, Baeza Trujillo M, Perucha Ortega M Clin Transl Oncol. 2023; 26(4):872-879.

PMID: 37672205 DOI: 10.1007/s12094-023-03315-1.

Targeting MicroRNAs in Prostate Cancer Radiotherapy.

Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y Theranostics. 2017; 7(13):3243-3259.

PMID: 28900507 PMC: 5595129. DOI: 10.7150/thno.19934.

Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation.

Sun S, Gu X, Gao X, Li Y, Yu H, Xiong W Oncotarget. 2016; 7(30):48050-48058.

PMID: 27385003 PMC: 5216999. DOI: 10.18632/oncotarget.10347.

Design considerations for a novel MRI compatible manipulator for prostate cryoablation.

Abdelaziz S, Esteveny L, Renaud P, Bayle B, Barbe L, de Mathelin M Int J Comput Assist Radiol Surg. 2011; 6(6):811-9.

PMID: 21484450 DOI: 10.1007/s11548-011-0558-4.

References

Kattan M, Potters L, Blasko J, Beyer D, Fearn P, Cavanagh W . Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology. 2001; 58(3):393-9. DOI: 10.1016/s0090-4295(01)01233-x. View

Horwitz E, Hanlon A, Pinover W, Anderson P, Hanks G . Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer. 2001; 92(5):1281-7. DOI: 10.1002/1097-0142(20010901)92:5<1281::aid-cncr1449>3.0.co;2-9. View

Zisman A, Pantuck A, Cohen J, Belldegrun A . Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology. 2001; 58(6):988-93. DOI: 10.1016/s0090-4295(01)01422-4. View

Izawa J, Madsen L, Scott S, McGuire E, von Eschenbach A, Pisters L . Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002; 20(11):2664-71. DOI: 10.1200/JCO.2002.06.086. View

Bahn D, Lee F, Badalament R, Kumar A, Greski J, Chernick M . Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002; 60(2 Suppl 1):3-11. DOI: 10.1016/s0090-4295(02)01678-3. View

Shinohara K, Connolly J, Presti Jr J, Carroll P . Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996; 156(1):115-20; discussion 120-1. View

Zietman A, Tibbs M, Dallow K, Smith C, Althausen A, Zlotecki R . Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate. Radiother Oncol. 1996; 40(2):159-62. DOI: 10.1016/0167-8140(96)01770-7. View

Cespedes R, Pisters L, Von Eschenbach A, McGuire E . Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol. 1997; 157(1):237-40. View

Wong W, Chinn D, Chinn M, CHINN J, Tom W . Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997; 79(5):963-74. View

10.

Pisters L, Von Eschenbach A, Scott S, Swanson D, Dinney C, Pettaway C . The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997; 157(3):921-5. View

11.

. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997; 37(5):1035-41. View

12.

Lee F, Bahn D, Mchugh T, Kumar A, Badalament R . Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up. Anticancer Res. 1997; 17(3A):1511-5. View

13.

Baust J, Gage A, Ma H, Zhang C . Minimally invasive cryosurgery--technological advances. Cryobiology. 1997; 34(4):373-84. DOI: 10.1006/cryo.1997.2017. View

14.

Chin J, Downey D, Mulligan M, Fenster A . Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results. J Urol. 1998; 159(3):910-4. View

15.

Crook J, Choan E, Perry G, Robertson S, Esche B . Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. Urology. 1998; 51(4):566-72. DOI: 10.1016/s0090-4295(97)00650-x. View

16.

Greene G, Pisters L, Scott S, Von Eschenbach A . Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol. 1998; 160(1):86-90. View

17.

Long J, Fallick M, LaRock D, Rand W . Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol. 1998; 159(2):477-84. DOI: 10.1016/s0022-5347(01)63953-3. View

18.

Schmidt J, Doyle J, Larison S . Prostate cryoablation: update 1998. CA Cancer J Clin. 1998; 48(4):239-53. DOI: 10.3322/canjclin.48.4.239. View

19.

Derakhshani P, Neubauer S, Braun M, Zumbe J, Heidenreich A, Engelmann U . Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results. Eur Urol. 1998; 34(3):181-7. DOI: 10.1159/000019709. View

20.

Mettlin C, Murphy G, Rosenthal D, Menck H . The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998; 83(8):1679-84. DOI: 10.1002/(sici)1097-0142(19981015)83:8<1679::aid-cncr24>3.0.co;2-y. View